Bringing the fundamentals into focus…
Back to Prelude Therapeutics Incorporated
How Prelude Therapeutics Incorporated stacks up
PRLD · against 353 other Healthcare companies of similar size
Profitability
10/ 100
Near the bottom of its peers.
Ranked #304 of 354 · scores higher than 12% of peers
Bars: peers in each 10-point band of the profitability score42 peers with a profitability score of 10–19, including PRLD · Click a bar to see the companies
Why profitability scores 10?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 91% of peers. Operating margin: -300.6% vs peer median 7.1%
- a lower return on invested capital: weaker than 88% of peers. Return on invested capital: -49.6% vs peer median 4.7%
- a lower return on assets: weaker than 87% of peers. Return on assets: -31.9% vs peer median 1.7%
Metric by metric
Position: dot = PRLD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRLD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 319 reported | -49.6% | -0.4% | 17% | 33% | |
| Operating marginHigher is better · 328 reported | -300.6% | 2.3% | 11% | 33% | |
| Return on assetsHigher is better · 354 reported | -31.9% | -0.4% | 16% | 33% | |
| Return on equityHigher is better · 333 reported | -57.7% | -1.6% | 14% | Context only | |
| Gross marginHigher is better · 369 reported | 100.0% | 36.9% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around PRLD| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 4 | 5.5B NOK (≈$523M) | 98 | 71 | |
| 4 | 261M USD | 98 | 97 | |
| 304 | 7.2B TWD (≈$224M) | 10 | 41 | |
| 304 | 377M USD | 10 | 29 | |
| 304 | 334M USD | 10 | 36 | |
| 304 | 255M USD | 10 | 36 | |
| 304 | 302M USD | 10 | 42 | |
| 304 | 504M USD | 10 | 24 | |
| 304 | 588M USD | 10 | 24 | |
| 311 | 395M USD | 9 | 30 | |
| 311 | 399M USD | 9 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score